{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:11:03Z","timestamp":1768371063134,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00108-025-01988-0","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:14:11Z","timestamp":1756995251000},"page":"105-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prim\u00e4r bili\u00e4re Cholangitis \u2013 Update zu Diagnostik, Risikostratifizierung und neuen Therapieoptionen","Primary biliary cholangitis\u2014Update on diagnostics, risk stratification and new treatment options"],"prefix":"10.1007","volume":"67","author":[{"given":"Toni","family":"Herta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"issue":"1","key":"1988_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"EASL Clinical Practice Guidelines","year":"2017","unstructured":"EASL Clinical Practice Guidelines (2017) The diagnosis and management of patients with primary biliary cholangitis. J\u00a0Hepatol 67(1):145\u2013172","journal-title":"J Hepatol"},{"issue":"2","key":"1988_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","volume":"127","author":"C Selmi","year":"2004","unstructured":"Selmi\u00a0C et\u00a0al (2004) Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127(2):485\u2013492","journal-title":"Gastroenterology"},{"issue":"1","key":"1988_CR3","doi-asserted-by":"publisher","first-page":"100202","DOI":"10.1016\/j.jhepr.2020.100202","volume":"3","author":"JK Dyson","year":"2021","unstructured":"Dyson\u00a0JK et\u00a0al (2021) Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis. Jhep Rep 3(1):100202","journal-title":"Jhep Rep"},{"issue":"1","key":"1988_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00535-021-01836-6","volume":"57","author":"K Matsumoto","year":"2022","unstructured":"Matsumoto\u00a0K et\u00a0al (2022) Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a\u00a0multicenter case-control study. J\u00a0Gastroenterol 57(1):19\u201329","journal-title":"J Gastroenterol"},{"issue":"4","key":"1988_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cld.2022.06.008","volume":"26","author":"M Shaker","year":"2022","unstructured":"Shaker\u00a0M, Mansour\u00a0N, John\u00a0BV (2022) Primary Biliary Cholangitis in Males: Pathogenesis, Clinical Presentation, and Prognosis. Clin Liver Dis 26(4):643\u2013655","journal-title":"Clin Liver Dis"},{"issue":"2","key":"1988_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/hep.20276","volume":"40","author":"RE Poupon","year":"2004","unstructured":"Poupon\u00a0RE et\u00a0al (2004) Quality of life in patients with primary biliary cirrhosis. Hepatology 40(2):489\u2013494","journal-title":"Hepatology"},{"issue":"7","key":"1988_CR7","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.cgh.2018.12.007","volume":"17","author":"VS Hegade","year":"2019","unstructured":"Hegade\u00a0VS et\u00a0al (2019) Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom. Clin Gastroenterol Hepatol 17(7):1379\u20131387.e3","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1988_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/PL00009532","volume":"12","author":"FW Mang","year":"1997","unstructured":"Mang\u00a0FW et\u00a0al (1997) Primary biliary cirrhosis, sicca complex, and dysphagia. Dysphagia 12(3):167\u2013170","journal-title":"Dysphagia"},{"key":"1988_CR9","unstructured":"[S3 guideline \u201cRare liver diseases (LeiSe LebEr)\u2014Autoimmune liver diseases from paediatrics to adulthood\u201d of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)]. Z Gastroenterol, 2025. 63(6): p.\u00a0604\u2013688."},{"issue":"1","key":"1988_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","volume":"12","author":"J Compston","year":"2017","unstructured":"Compston\u00a0J et\u00a0al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12(1):43","journal-title":"Arch Osteoporos"},{"key":"1988_CR11","doi-asserted-by":"publisher","first-page":"102578","DOI":"10.1016\/j.jaut.2020.102578","volume":"116","author":"B Terziroli Beretta-Piccoli","year":"2021","unstructured":"Terziroli Beretta-Piccoli\u00a0B et\u00a0al (2021) Primary biliary cholangitis with normal alkaline phosphatase: A\u00a0neglected clinical entity challenging current guidelines. J\u00a0Autoimmun 116:102578","journal-title":"J Autoimmun"},{"issue":"5","key":"1988_CR12","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/hep.510250507","volume":"25","author":"P Invernizzi","year":"1997","unstructured":"Invernizzi\u00a0P et\u00a0al (1997) Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 25(5):1090\u20131095","journal-title":"Hepatology"},{"issue":"1","key":"1988_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hep.28859","volume":"65","author":"G Dahlqvist","year":"2017","unstructured":"Dahlqvist\u00a0G et\u00a0al (2017) Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis. Hepatology 65(1):152\u2013163","journal-title":"Hepatology"},{"issue":"5","key":"1988_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/MCG.0000000000001433","volume":"55","author":"KT Osman","year":"2021","unstructured":"Osman\u00a0KT et\u00a0al (2021) Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis. J\u00a0Clin Gastroenterol 55(5):449\u2013457","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"1988_CR15","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jhep.2022.06.017","volume":"77","author":"C Corpechot","year":"2022","unstructured":"Corpechot\u00a0C et\u00a0al (2022) Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis. J\u00a0Hepatol 77(6):1545\u20131553","journal-title":"J Hepatol"},{"key":"1988_CR16","doi-asserted-by":"crossref","unstructured":"Levy C, Bowlus CL (2024) Primary biliary cholangitis: Personalizing second-line therapies. Hepatology","DOI":"10.1097\/HEP.0000000000001166"},{"issue":"2","key":"1988_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","volume":"71","author":"MH Harms","year":"2019","unstructured":"Harms\u00a0MH et\u00a0al (2019) Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. J\u00a0Hepatol 71(2):357\u2013365","journal-title":"J Hepatol"},{"issue":"4","key":"1988_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","volume":"148","author":"GM Hirschfield","year":"2015","unstructured":"Hirschfield\u00a0GM et\u00a0al (2015) Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology 148(4):751\u2013761.e8","journal-title":"Gastroenterology"},{"issue":"7","key":"1988_CR19","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.14309\/ajg.0000000000000557","volume":"115","author":"CF Murillo Perez","year":"2020","unstructured":"Murillo Perez\u00a0CF et\u00a0al (2020) Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase. Am J Gastroenterol 115(7):1066\u20131074","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1988_CR20","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/hep.31810","volume":"74","author":"L Cristoferi","year":"2021","unstructured":"Cristoferi\u00a0L et\u00a0al (2021) Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Na\u00efve Patients With Primary Biliary Cholangitis: A\u00a0Dual Cut-Off Approach. Hepatology 74(3):1496\u20131508","journal-title":"Hepatology"},{"issue":"8","key":"1988_CR21","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.cgh.2020.08.006","volume":"19","author":"A Gerussi","year":"2021","unstructured":"Gerussi\u00a0A et\u00a0al (2021) Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol 19(8):1688\u20131697.e1","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"23","key":"1988_CR22","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","volume":"378","author":"C Corpechot","year":"2018","unstructured":"Corpechot\u00a0C et\u00a0al (2018) A\u00a0Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis. N\u00a0Engl J Med 378(23):2171\u20132181","journal-title":"N Engl J Med"},{"issue":"3","key":"1988_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jhep.2021.04.010","volume":"75","author":"A Tanaka","year":"2021","unstructured":"Tanaka\u00a0A et\u00a0al (2021) Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis. J\u00a0Hepatol 75(3):565\u2013571","journal-title":"J Hepatol"},{"issue":"3","key":"1988_CR24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/j.gastro.2020.10.001","volume":"160","author":"E de Vries","year":"2021","unstructured":"de Vries\u00a0E et\u00a0al (2021) Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A\u00a0Double-Blind, Randomized, Placebo-Controlled Trial. Gastroenterology 160(3):734\u2013743.e6","journal-title":"Gastroenterology"},{"issue":"11","key":"1988_CR25","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.14309\/ajg.0000000000002238","volume":"118","author":"Y Liu","year":"2023","unstructured":"Liu\u00a0Y et\u00a0al (2023) Effectiveness of Fenofibrate in Treatment-Naive Patients With Primary Biliary Cholangitis: A\u00a0Randomized Clinical Trial. Am J Gastroenterol 118(11):1973\u20131979","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1988_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2306185","volume":"390","author":"KV Kowdley","year":"2024","unstructured":"Kowdley\u00a0KV et\u00a0al (2024) Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis. N\u00a0Engl J Med 390(9):795\u2013805","journal-title":"N Engl J Med"},{"issue":"9","key":"1988_CR27","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJMoa2312100","volume":"390","author":"GM Hirschfield","year":"2024","unstructured":"Hirschfield\u00a0GM et\u00a0al (2024) A\u00a0Phase\u00a03 Trial of Seladelpar in Primary Biliary Cholangitis. N\u00a0Engl J Med 390(9):783\u2013794","journal-title":"N Engl J Med"},{"key":"1988_CR28","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines on genetic cholestatic liver diseases. J\u00a0Hepatol, 2024. 81(2): p.\u00a0303\u2013325.","DOI":"10.1016\/j.jhep.2024.04.006"},{"issue":"6","key":"1988_CR29","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","volume":"102","author":"MG Silveira","year":"2007","unstructured":"Silveira\u00a0MG et\u00a0al (2007) Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 102(6):1244\u20131250","journal-title":"Am J Gastroenterol"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01988-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-01988-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01988-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:04:55Z","timestamp":1768352695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-01988-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1988"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-01988-0","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"20 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Herta und T.\u00a0Berg geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}